RE: The UK gov budget has to be for antigen testing06 Jul 2020 15:42
Well Awacta have £10m put aside to ramp up production from our side, news on manufacturers is due soon and I’m sure more will be added as time goes on. To answer your question, no, we won’t be able to keep up with global demand. Not a terrible problem to have... a licence to print cash and not enough printers.
Got to say it’s the most dreary miserable BB I’ve been on. I optimistically jump on and within 5 minutes I find myself writing a letter and running a warm bath. Be patient, cheer up, anything other than the pure misery...
It’ll come good. Just give it some time. Covid is still rising exponentially along with a need for testing. We’re due some sort of update soon, it’s now early July at last! So let’s relax a bit, see what happens and stop crying before we get hurt.
Appears to have been written about something currently in development. A British company lining up a range of manufacturers in the UK to produce a high performance test that will be used in workplaces and in the home. Not long now, ignore the noise.
AW, are you talking about the same govt that have said this:
The fifth pillar is the most ambitious. We want to build in a short space of time, the large diagnostics industry that this country currently lacks. Just as our top end manufacturers have joined the national effort to build ventilators, so our life sciences companies will do the same for testing. UK pharmaceutical giants which do not have a tradition of diagnostics, are now working with our world leading but smaller diagnostics companies, to build a British diagnostics industry at scale. This new national effort for testing will ensure we can get tests for everyone who needs them.
We are therefore asking industry to work with us on how this can best be achieved. We want proposals for new national industrial capability that meets a set of clear principles:
It must be flexible, able to quickly adapt both the tests themselves and the delivery of those tests as the virus and our response evolves over time. We want to explore increasingly decentralised models of testing, moving away from central labs to testing in local hospitals, at work or in the home The solutions must enable testing at huge scale, but with extremely high levels of accuracy and sensitivity. An unreliable test is worse than no test It needs to be resilient - the end to end supply chain for the test should be domestically based as far as practically possible, with a clear and deliverable plan for the capacity and capability to deliver the scale of testing we need It must be as open source as possible with the ability for components, consumables, chemicals and digital components to be produced by a range of manufacturers – quickly and easily. And it should be clear how new companies can join and contribute to the approach
Boohoo are having quite a scrap with Shadowfall and this recent news gives them another chance to short their stock. It’s hardly new news, just google fast fashion and modern slavery and you’ll find similar stories about ASOS, H&M and others. Boohoo will just deny all knowledge and if any mud looks likely to stick they’ll just drop that supplier.
Suggesting any of the above in anyway impacts medusa19, a start up distribution company of diagnostic tests is ridiculous.
I don’t think you could have high expectations as it’s truly groundbreaking, but certainly very high hopes based on progress to date. Sir Al recently commented on the current share price and felt that it reflected fair value based ignoring Covid. They’ve recently raised £48m from investors including Ruane and Sequoia Flooring. Given that was at 120p and conversations started a year ago, it’s clear there’s a lot of potential.
Digging out NBC News who are reporting yet more phenomenal stupidity from trump. Click through to the article, looks like his latest thinking is just to put his head in the sand. A mention of therapeutics though even if they’re thick enough to ignore testing.
RE: Look at the serious players invested in GDR05 Jul 2020 13:17
I agree Grim and we’re hopefully on the brink of that re-rating. I’m not expecting fireworks but some solid rises based on approvals and what’s to come. The fireworks can come shortly after, but if DB has a display set up and ready to go I’ll be first in line. Oooooh! Aaaaaah! Wooooah!
They go hand in hand, the call for rapid antigen tests in India was to reduce the costs and strain on PCR testing. It references the throughput and costs of PCR, hopefully this provides the opportunity for GDR with our more efficient test. As you’ve noted, there’s also the rest of the globe to aim at.